02212nas a2200289 4500000000100000008004100001260001200042653001800054653001200072653001700084653001200101653002300113100001300136700001200149700001200161700001300173700001100186700001200197700001100209700001500220245009000235856007900325300000800404490000600412520149000418022001401908 2023 d c12/202310aCote d'Ivoire10aDaoukro10aEpidemiology10aleprosy10aSub-Saharan Africa1 aTetchi E1 aKonan Y1 aKpebo D1 aDjoman M1 aEkou F1 aSable P1 aYapi A1 aTano-Ake O00a[Leprosy epidemiology in Daoukro health district (Côte d'Ivoire) from 1999 to 2017]. uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10879886/pdf/mtsi-03-5420.pdf a1-70 v33 a

English Abstract:

Introduction: Leprosy is a real problem in the Daoukro health district despite the actions of the National programme for elimination.

Objective: To describe the epidemiological and clinical profile of new leprosy cases in the Daoukro health district from 1999 to 2017.

Method: Descriptive survey including leprosy patients admitted to the dermato-leprology department from 1999 to 2017.

Results: From 1999 to 2017, the incidence of leprosy fluctuated from 4.4 to 0 per 100,000 with a peak of 14.2 in 2003. In 2016 and 2017 no cases of leprosy were reported. The mean age was 36.8 years (SD=20). A majority of cases were uneducated and living in rural areas. Females and children under 15 years of age accounted for 53% and 16% of cases respectively. Clinically, cutaneous signs were predominant in the patients. The multibacillary form accounted for 82%. Nearly 1 out of 4 patients had a grade 2 disability (24%). All patients received treatment (multidrug therapy). Among them, 83.8% were cured, while 0.5% were not cured. In addition, regarding 29 patients (15.7%) details of how their disease progressed were not available. Among the patients declared cured, 26% had sequels.

Conclusion: Leprosy control activities must be strengthened in order to maintain the achievements in this non-endemic district.

 a2778-2034